Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Bwx Technologies Inc (NY: BWXT )

60.95 +0.45 (+0.74%)
Official Closing Price Updated: 7:00 PM EST, Jan 26, 2023 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 479,704
Open 60.93
Bid (Size) 60.36 (1)
Ask (Size) 61.07 (1)
Prev. Close 60.50
Today's Range 60.42 - 61.18
52wk Range 42.58 - 62.84
Shares Outstanding 95,176,522
Dividend Yield 1.38%
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year

Top News

More News
BWX Technologies to Announce Fourth Quarter and Full-Year 2022 Results on Thursday, February 23
From BWX Technologies, Inc.
Via Business Wire
BWX Technologies Stock Showing Rising Market Leadership; Earns 81 RS Rating
On Wednesday, BWX Technologies stock had its Relative Strength (RS) Rating upgraded to 81, up from 75 a day earlier. 
Via Investor's Business Daily

Performance

YTD
+5.82%
+5.82%
1 Month
+4.80%
+4.80%
3 Month
+9.09%
+9.09%
6 Month
+11.75%
+11.75%
1 Year
+27.91%
+27.91%

More News

Read More
Fusion Pharmaceuticals and BWXT Medical Announce Actinium-225 Partnership to Scale Supply for Developing Targeted Alpha Therapies
From BWX Technologies, Inc.
Via Business Wire
BWXT Promotes Chip Whitford to Senior Vice President and General Counsel
From BWX Technologies, Inc.
Via Business Wire
BWX Technologies: Q2 Earnings Insights
Via Benzinga
BWXT Canada Secures C$130M Component Manufacturing Contract
Via Benzinga
The 7 Hottest Defense Stocks to Own for 2023 and Beyond
Via InvestorPlace
BWXT Starts Production of TRISO Fuel for First U.S. Generation IV Microreactor
From BWX Technologies, Inc.
Via Business Wire
BWX Technologies Reports Third Quarter 2022 Results
From BWX Technologies, Inc.
Via Business Wire
BWXT to Participate in Upcoming Investor Conferences
From BWX Technologies, Inc.
Via Business Wire
BWXT Medical, TRIUMF Agree To Manufacture High Purity Ac-225 Based Products
Via Benzinga
BWXT Closes Amended and Restated Credit Agreement
From BWX Technologies, Inc.
Via Business Wire
Credit Suisse Picks 7 Aerospace, Defense Stocks To Buy — And 4 To Avoid
Via Benzinga
BWX Technologies to Announce Third Quarter 2022 Results on Monday, November 7
From BWX Technologies, Inc.
Via Business Wire
BWXT Medical Submits Tc-99m Generator New Drug Application to FDA
From BWX Technologies, Inc.
Via Business Wire
Benzinga's Top Ratings Upgrades, Downgrades For October 12, 2022
Via Benzinga
7 Defense Stocks With Dividends You Can Count On
Via InvestorPlace
BWXT Names Robert Duffy as Chief Administrative Officer
From BWX Technologies, Inc.
Via Business Wire
12 Industrials Stocks Moving In Monday's After-Market Session
Via Benzinga
BWX Technologies Reports Robust Second Quarter 2022 Results; Increases 2022 Revenue and Adjusted EBITDA(1) Guidance
From BWX Technologies, Inc.
Via Business Wire
BWXT Names Sharon H. Smoot as President of Nuclear Operations Group
From BWX Technologies, Inc.
Via Business Wire
BWX Technologies to Announce Second Quarter 2022 Results on Monday, August 8
From BWX Technologies, Inc.
Via Business Wire
BWXT Canada Awarded CA$130 Million Component Manufacturing Contract from Bruce Power
From BWX Technologies, Inc.
Via Business Wire
BWXT Medical, Bayer Ink Commercial Agreement For Actinium-225 Based Products
Via Benzinga
BWXT Medical Executes Commercial Agreement with Bayer for Supply of Actinium-225 Based Products
From BWX Technologies, Inc.
Via Business Wire
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.